Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118955504B reveals visible light cobalt catalysis for hexahydro beta carboline indole compounds offering safer greener pharmaceutical intermediate manufacturing supply chain advantages.
Novel 3-step route for Rivaroxaban intermediate reduces waste and cost. High purity API intermediate manufacturing via efficient isonitrification.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Patent CN102675283A reveals a novel acid-catalyzed condensation route for Bepotastine intermediates, offering superior chiral purity and yield compared to traditional base-mediated methods.
Optimized Dasatinib synthesis patent CN103554099B ensures high purity and stability. Delivers significant cost reduction and supply chain reliability for API manufacturing.
Advanced preparation method for Phenoxybenzamine Hydrochloride via CN102887830B. High-purity pharmaceutical intermediates with optimized cost reduction and scalable manufacturing processes.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Patent CN107988307A details enzymatic resolution for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN102827015A details a novel nitroacetate-based synthesis for ALA HCl, offering cost reduction and scalability for pharmaceutical intermediates without heavy metals.
Novel patent CN104098556A enables high-purity Rivaroxaban intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN112125942A reveals a novel chlorination route for Abiraterone Acetate intermediates, offering higher purity and yield compared to traditional iodination methods for scalable manufacturing.
Patent CN119176829B reveals a novel substitution reaction achieving high yield and low impurity. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel microwave synthesis method for dihydrazide phthalazine intermediates offers high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN106588746B reveals a green hydrogenation route for Gliclazide side chain. Offers high purity, catalyst recycling, and cost reduction for pharmaceutical manufacturing.
Advanced synthesis of stable Clopidogrel Hydrogen Sulfate Form II via optimized solvent strategy. High purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN111793037B reveals advanced crystallization for 3,6-difluoropyrazine-2-carbonitrile. Ensures supply chain reliability and cost reduction.
Patent CN102786498A details a novel Repaglinide synthesis using CDI coupling and optimized deprotection, offering significant cost reduction and scalability for API manufacturing.